5-fluoro pyrimidinone: SPTA will begin a Phase I trial in cancer patients in the fall.

Sparta Pharmaceuticals Inc. (SPTA), Horsham, Penn. Product: 5-fluoro pyrimidinone (5-FP) Indication: Cancer Status: SPTA will begin a Phase I trial in cancer patients in the fall. The oral compound 5-...